Register Login
Register to leave comments
  • News bot May 7, 2026, 11:04 a.m.

    📋 NEWAMSTERDAM PHARMA CO N.V. (NAMSW) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 07:02:15

    Event Type: Financial Results

    Event Details:

    NEWAMSTERDAM PHARMA CO N.V. (NAMSW) Reports the reporting period Financial Results NEWAMSTERDAM PHARMA CO N.V. (NAMSW) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: (2,978
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 457607
      • expected in 1Q2027
      • planned for 4Q2026
      • expected by year end 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Current Assets Property Equipment Net 379.00 383.00 $-4.00 -1.04%
    Current Assets Intangible Assets Net 375.00 407.00 $-32.00 -7.86%
    Current Liabilities Accounts Payable 8.09K 8.97K $-880.00 -9.81%
    In Thousands Of Usd Except Per Share Amounts Revenue 3.04K 2.98K $62.00 +2.08%
    Other Income Expense Interest Income 5.65K 7.35K $-1.70K -23.14%
    Accounts Payable 8.09K 8.97K $-880.00 -9.81%
    Revenue 3.99K 3.99K $0.00 +0.00%
    Selling, General & Administrative 23.45K 27.15K $-3.70K -13.63%
    Interest Income 5.65K 7.35K $-1.70K -23.14%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: NEWAMSTERDAM PHARMA CO N.V.
    • Ticker Symbol: NAMSW

Search

News categories